Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for GAL 9
Most Correlated Studies
- L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
- L1000 CMAP - Lung cancer A549 cells treated with ligand perturbagens
- L1000 CMAP - Non-small cell lung cancer HCC515 cells treated with ligand perturbagens
- L1000 CMAP - Carcinoma of prostate PC3 cells treated with ligand perturbagens
- L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
Most Relevant Literature
- Galectin-9 Is a Novel Regulator of Epithelial Restitution.
- Galectin-9 regulates follicular helper T cells to inhibit humoral autoimmunity-induced pulmonary fib…
- Obesity-induced galectin-9 is a therapeutic target in B-cell acute lymphoblastic leukemia.
- Galectin-9 in synergy with NF-κB inhibition restores immune regulatory capability in dendritic cells…
- Sensing of mycobacterial arabinogalactan by galectin-9 exacerbates mycobacterial infection.
Most Relevant Clinical Trials
- Characterisation of TIM-3/Gal-9 Immune Checkpoints in Primary Central Nervous System Diffuse Large B…
- Intratumoral Injection Of Alpha-Gal Glycosphingolipids
- Evaluation of Serum Galectin-9 Level in Systemic Lupus Erythematosus Patients and it's Association W…
- Assessment of Galectin-9 in Rheumatoid Arthritis and Its Correlation With Disease Activity
- The Role of Galectins in the Non-invasive Diagnosis of Endometriosis
